The World Health Organization declared smallpox, a contagious and sometimes fatal infectious disease, eradicated in 1980. However, there have been longstanding concerns that smallpox may be used as a bioweapon.  Also known as ST-246, it is the first approved drug for smallpox,.  it has been studied for the treatment of smallpox, monkeypox, orthopoxvirus, and orthopoxviral Disease. The U.S. Food and Drug Administration approved it (as TPOXX) on July 13, 2018 for the treatment of smallpox. it is an orally available small molecule with activity against orthopoxviruses. it is an inhibitor of viral p37 and blocks the ability of virus particles to be released from infected cells. 
